Product information and disease descriptionProduct descriptionProduct information
Special populations
1 evidence topic · 1 source
PEAK eligibility: adult participants
Organ impairment and pregnancy
No evidence found.
Bezuclastinib
Gastrointestinal stromal tumor
- Manufacturer
- Cogent Biosciences
- Regulatory submission
- NDA submitted April 2026
- Last updated